EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis of 1,2,4-Oxadiazin-5(6H)-One Derivatives and Their Biological Investigation as Monoamine Oxidase Inhibitors

Sofia I Presnukhina iD, Valentina D Kotlyarova iD, Anton A Shetnev iD, Sergey V Baykov iD, Rakhymzhan Turmanov iD, Nurbol Appazov, Rakhmetulla Zhapparbergenov, Leilya Zhussupova, Nurila Togyzbayeva, Stephanus J Cloete iD, Mikhail K Korsakov iD, Vadim P Boyarskiy iD und 2 weitere

Molecules · 2024

DOI: 10.3390/molecules29235550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Sofia I Presnukhina und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry, Saint Petersburg State University, Universitetskaya Nab., 7/9, 199034 Saint Petersburg, Russia. Hauptthemen laut MEDLINE: Monoamine Oxidase Inhibitors, Monoamine Oxidase. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan, National Research Foundation of South Africa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monoamine oxidase (MAO) plays a key role in the pathogenesis of central nervous system disorders, and MAO inhibitors have been used in the treatment of depression and Parkinson’s disease. In the search for new classes of MAO inhibitors, the present study investigated a series of 1,2,4-oxadiazin-5(6H)-one derivatives. This study provides the first optimization of the reaction conditions for the condensation of amidoximes with alkyl 2-halocarboxylates to yield the desired 1,2,4-oxadiazin-5(6H)-ones. The results of the in vitro MAO inhibition studies showed that the 1,2,4-oxadiazin-5(6H)-ones were indeed inhibitors of human MAO with the most potent inhibition observed for 5f (IC50 = 0.900 µM) and 7c (IC50 = 0.371 µM). It was concluded that, with appropriate substitution, 1,2,4-oxadiazin-5(6H)-one derivatives would act as good potency MAO-B inhibitors and lead compounds for the development of antiparkinsonian drugs. In Parkinson’s disease, MAO-B inhibitors enhance central dopamine levels and reduce MAO-mediated production of hydrogen peroxide and resultant oxidative injury. This study represents one of few works to investigate synthetic approaches and biological activities of the 1,2,4-oxadiazin-5(6H)-one class of heterocycles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monoamine Oxidase InhibitorsMonoamine OxidaseHumansStructure-Activity RelationshipMolecular StructureParkinson DiseaseOxazines

Stichwörter der Autor:innen

MAOParkinson’s diseaseinhibitionmonoamine oxidaseoxadiazine

Substanzen

Monoamine Oxidase InhibitorsMonoamine OxidaseOxazines

Autor:innen und Institutionen

  • Institute of Chemistry, Saint Petersburg State University, Universitetskaya Nab., 7/9, 199034 Saint Petersburg, Russia.
  • Pharmaceutical Technology Transfer Centre, Yaroslavl State Pedagogical University Named after K.D. Ushinsky, Respublikanskaya St., 108, 150000 Yaroslavl, Russia.
  • Laboratory of Engineering Profile "Physical and Chemical Methods of Analysis", Korkyt Ata Kyzylorda University, 29 Aiteke Bi Str., Kyzylorda 120014, Kazakhstan.
  • Moscow Center for Advanced Studies, 20, Kulakova Str., 123592 Moscow, Russia.
  • "DPS Kyzylorda" LLP, Amangeldy Imanov Str., 112A, Kyzylorda 120008, Kazakhstan.
  • "CNEC" LLP, Dariger Ali Lane, 2, Kyzylorda 120001, Kazakhstan.

ORCID-Profile: Sofia I Presnukhina, Valentina D Kotlyarova, Anton A Shetnev, Sergey V Baykov, Rakhymzhan Turmanov, Stephanus J Cloete, Mikhail K Korsakov, Vadim P Boyarskiy, Jacobus P Petzer

Förderung

  • Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan
  • National Research Foundation of South Africa

Zitieren

APA

Presnukhina, S. I., Kotlyarova, V. D., Shetnev, A. A., Baykov, S. V., Turmanov, R., Appazov, N., Zhapparbergenov, R., Zhussupova, L., Togyzbayeva, N., Cloete, S. J., Korsakov, M. K., Boyarskiy, V. P., Petzer, A., & Petzer, J. P. (2024). Synthesis of 1,2,4-Oxadiazin-5(6H)-One Derivatives and Their Biological Investigation as Monoamine Oxidase Inhibitors. Molecules. https://doi.org/10.3390/molecules29235550

Vancouver

Presnukhina SI, Kotlyarova VD, Shetnev AA, Baykov SV, Turmanov R, Appazov N, et al. Synthesis of 1,2,4-Oxadiazin-5(6H)-One Derivatives and Their Biological Investigation as Monoamine Oxidase Inhibitors. Molecules. 2024. doi:10.3390/molecules29235550

BibTeX
@article{Presnukhina2024,
  author = {Presnukhina, Sofia I and Kotlyarova, Valentina D and Shetnev, Anton A and Baykov, Sergey V and Turmanov, Rakhymzhan and Appazov, Nurbol and Zhapparbergenov, Rakhmetulla and Zhussupova, Leilya and Togyzbayeva, Nurila and Cloete, Stephanus J and Korsakov, Mikhail K and Boyarskiy, Vadim P and Petzer, Anél and Petzer, Jacobus P},
  title = {Synthesis of 1,2,4-Oxadiazin-5(6H)-One Derivatives and Their Biological Investigation as Monoamine Oxidase Inhibitors},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29235550}
}
Kostenlos starten →